Diabetic eNOS knockout mice develop distinct macro- and microvascular complications - PubMed (original) (raw)
Diabetic eNOS knockout mice develop distinct macro- and microvascular complications
Sumathy Mohan et al. Lab Invest. 2008 May.
Free article
Abstract
Functional consequences of impaired endothelial nitric oxide synthase (eNOS) activity causing organ-specific abnormalities on a diabetic setting are not completely understood. In this study, we extensively characterized a diabetic mouse model (lepr(db/db)) in which eNOS expression is genetically disrupted (eNOS-/-). The eNOS-/-/ lepr(db/db) double-knockout (DKO) mice developed obesity, hyperglycemia, hyperinsulinemia and hypertension. Analysis of tissues from DKO mice showed large islets in the pancreas and fat droplets in hepatocytes. Interestingly, the aorta was normal and atherogenic lesions were not observed. Abnormalities in the aorta including poor re-endothelialization and increased medial wall thickness were evident only in response to deliberate injury. In contrast, significant glomerular capillary damage in the kidney was identified, with DKO mice demonstrating a robust diabetic nephropathy similar to human disease. The vascular and renal impairments in DKO mice were pronounced despite lower fasting plasma glucose levels compared to lepr(db/db) mice, indicating that eNOS is a critical determinant of hyperglycemia-induced organ-specific complications and their severity in diabetes. Results provide the first evidence that absence of eNOS in diabetes has a greater deleterious effect on the renal microvasculature than on the larger aortic vessel. The DKO model may suggest novel therapeutic strategies to prevent both vascular and renal complications of diabetes.
Similar articles
- Comparison of diabetic nephropathy between male and female eNOS-/-db/db mice.
Ma Y, Li W, Yazdizadeh Shotorbani P, Dubansky BH, Huang L, Chaudhari S, Wu P, Wang LA, Ryou MG, Zhou Z, Ma R. Ma Y, et al. Am J Physiol Renal Physiol. 2019 May 1;316(5):F889-F897. doi: 10.1152/ajprenal.00023.2019. Epub 2019 Feb 27. Am J Physiol Renal Physiol. 2019. PMID: 30810354 Free PMC article. - Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.
Kanetsuna Y, Takahashi K, Nagata M, Gannon MA, Breyer MD, Harris RC, Takahashi T. Kanetsuna Y, et al. Am J Pathol. 2007 May;170(5):1473-84. doi: 10.2353/ajpath.2007.060481. Am J Pathol. 2007. PMID: 17456755 Free PMC article. - Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.
Zhao HJ, Wang S, Cheng H, Zhang MZ, Takahashi T, Fogo AB, Breyer MD, Harris RC. Zhao HJ, et al. J Am Soc Nephrol. 2006 Oct;17(10):2664-9. doi: 10.1681/ASN.2006070798. Epub 2006 Sep 13. J Am Soc Nephrol. 2006. PMID: 16971655 Free PMC article. - Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice.
Takahashi T, Harris RC. Takahashi T, et al. J Diabetes Res. 2014;2014:590541. doi: 10.1155/2014/590541. Epub 2014 Oct 13. J Diabetes Res. 2014. PMID: 25371905 Free PMC article. Review. - [Endothelial function and the microcirculation in diabetes mellitus].
Arosio E, Minuz P, Prior M. Arosio E, et al. Ann Ital Med Int. 1999 Apr-Jun;14(2):106-13. Ann Ital Med Int. 1999. PMID: 10399372 Review. Italian.
Cited by
- Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice.
Cheng H, Wang H, Fan X, Paueksakon P, Harris RC. Cheng H, et al. Kidney Int. 2012 Dec;82(11):1176-83. doi: 10.1038/ki.2012.248. Epub 2012 Jul 11. Kidney Int. 2012. PMID: 22785174 Free PMC article. - A meta-analysis of three polymorphisms in the endothelial nitric oxide synthase gene (NOS3) and their effect on the risk of diabetic nephropathy.
Zeng Z, Li L, Zhang Z, Li Y, Wei Z, Huang K, He L, Shi Y. Zeng Z, et al. Hum Genet. 2010 Apr;127(4):373-81. doi: 10.1007/s00439-009-0783-x. Epub 2010 Jan 5. Hum Genet. 2010. PMID: 20049477 Review. - Abnormalities in signaling pathways in diabetic nephropathy.
Brosius FC, Khoury CC, Buller CL, Chen S. Brosius FC, et al. Expert Rev Endocrinol Metab. 2010;5(1):51-64. doi: 10.1586/eem.09.70. Expert Rev Endocrinol Metab. 2010. PMID: 20224802 Free PMC article. - Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism.
Advani A, Huang Q, Thai K, Advani SL, White KE, Kelly DJ, Yuen DA, Connelly KA, Marsden PA, Gilbert RE. Advani A, et al. Am J Pathol. 2011 May;178(5):2205-14. doi: 10.1016/j.ajpath.2011.01.044. Am J Pathol. 2011. PMID: 21514434 Free PMC article. - Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats.
Sheldon RD, Laughlin MH, Rector RS. Sheldon RD, et al. J Appl Physiol (1985). 2014 May 1;116(9):1156-64. doi: 10.1152/japplphysiol.01275.2013. Epub 2014 Feb 27. J Appl Physiol (1985). 2014. PMID: 24577062 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous